Valneva (VALN) Stock Price, Quote, News & History | Benzinga

Valneva SE (VALN) Stock Price, Quote, News & History

VALNNASDAQ

Trade with Public

Trade with Public

$6.56

-0.14-2.02%

At close: Aug 27, 5:00 PM EST

$6.66

0.101.52%

After Hours: 9:29 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Stock Report

Key Statistics

Open

$6.66

Close

$6.56

Volume / Avg.

21.50K / 75.57K

Day Range

$6.54 - $6.66

52 Wk Range

4.75 - 12.23

Market Cap

$631.52M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

63

Short Interest

0.17%

Days to Cover

1

Recent Valneva SE News

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Benzinga readers can review the latest analyst takes on high-yielding stocks in health care sector. Top analysts & recent news on PRGO, PFE, BMY.

Avi Kapoor

Applied Optoelectronics, SanDisk, Seagate And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

Stock futures mixed, Nasdaq 100 down 100 points. Applied Optoelectronics falls after announcing $600M offering. Other pre-market losers include RFAI, ZSTK, ZKH, JMIA, VALN, MFI, COHR, SNDK, AXTI, ASTL, LITE, STX.

Avi Kapoor

European Regulator Validates Pfizer and Valneva's Lyme Disease Vaccine Application

Valneva (VALN) stock surges after EMA validates MAA for Lyme disease vaccine candidate developed with Pfizer (PFE). Phase 3 trial showed efficacy and no safety concerns, pending regulatory approval.

Vandana Singh

Dow Falls Over 100 Points; US Consumer Sentiment Declines In August

Dow falls 0.26% while Nasdaq drops 0.51%. Energy shares rise 1.3%, tech stocks fall 0.6%. US retail sales down 0.6%, consumer sentiment declines.

Avi Kapoor

Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday

U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-55.69M

Investing Cash Flow (TTM)

564.00K

Financing Cash Flow (TTM)

14.57M

Free Cash Flow (TTM)

-58.04M

Capital Expenditure (TTM)

-2.35M

Net Change in Cash (TTM)

-40.56M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$732.33M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

3.58

PB Ratio (TTM)

6.70

Earnings Yield % (TTM)

-31.39%

Earnings Yield % (FWD)

-15.70%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.00

Company Debt

Total Debt

$184.06M

LT Debt

$165.63M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$174.83M

Total Cash

$121.53M

Debt to Equity

2.59

Issuance of Debt (TTM)

-$432.00K

Repayment of Debt (TTM)

-$174.83M

Key Statistics

Open

$6.66

Close

$6.56

Volume / Avg.

21.50K / 75.57K

Day Range

$6.54 - $6.66

52 Wk Range

4.75 - 12.23

Market Cap

$631.52M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

63

Short Interest

0.17%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESP...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Valneva (VALN) stock?

A

You can purchase shares of Valneva (NASDAQ:VALN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Valneva (VALN) competitors?

A

Other companies in Valneva’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Valneva (VALN) stock?

A

Valneva has a consensus price target of $16.00.

Q

What is the current price for Valneva (VALN)?

A

The stock price for Valneva (NASDAQ: VALN) is $6.66 last updated August 27, 2026 at 9:29 AM EDT.

Q

Does Valneva (VALN) pay a dividend?

A

There are no upcoming dividends for Valneva.

Q

When is Valneva (NASDAQ:VALN) reporting earnings?

A

Valneva does not have any upcoming earnings scheduled.

Q

Is Valneva (VALN) going to split?

A

There is no upcoming split for Valneva.

Q

What sector and industry does Valneva (VALN) operate in?

A

Valneva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.